These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy. Liu AJ, Jones MP, Murray H, Cook CM, Nanan R. Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243 [Abstract] [Full Text] [Related]
4. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. Dryden C, Young D, Hepburn M, Mactier H. BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239 [Abstract] [Full Text] [Related]
6. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Kakko J, Heilig M, Sarman I. Drug Alcohol Depend; 2008 Jul 01; 96(1-2):69-78. PubMed ID: 18355989 [Abstract] [Full Text] [Related]
8. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Binder T, Vavrinková B. Neuro Endocrinol Lett; 2008 Feb 01; 29(1):80-6. PubMed ID: 18283247 [Abstract] [Full Text] [Related]
9. Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine. Sarfi M, Martinsen H, Bakstad B, Røislien J, Waal H. Early Hum Dev; 2009 Dec 01; 85(12):773-8. PubMed ID: 19931991 [Abstract] [Full Text] [Related]
10. Visual evoked potentials in infants exposed to methadone in utero. McGlone L, Mactier H, Hamilton R, Bradnam MS, Boulton R, Borland W, Hepburn M, McCulloch DL. Arch Dis Child; 2008 Sep 01; 93(9):784-6. PubMed ID: 18305073 [Abstract] [Full Text] [Related]
11. Perinatal effects of amphetamine and heroin use during pregnancy on the mother and infant. Thaithumyanon P, Limpongsanurak S, Praisuwanna P, Punnahitanon S. J Med Assoc Thai; 2005 Nov 01; 88(11):1506-13. PubMed ID: 16471094 [Abstract] [Full Text] [Related]
12. [Substitution treatment of drug addicts during pregnancy: consequences for the children?]. Sandtorv L, Reigstad H, Bruarøy S, Elgen I, Laegreid LM. Tidsskr Nor Laegeforen; 2009 Feb 12; 129(4):287-90. PubMed ID: 19219093 [Abstract] [Full Text] [Related]
15. Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Miles J, Sugumar K, Macrory F, Sims DG, D'Souza SW. Child Care Health Dev; 2007 Mar 12; 33(2):206-12. PubMed ID: 17291325 [Abstract] [Full Text] [Related]
16. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Hunt RW, Tzioumi D, Collins E, Jeffery HE. Early Hum Dev; 2008 Jan 12; 84(1):29-35. PubMed ID: 17728081 [Abstract] [Full Text] [Related]
17. A four year survey of neonatal narcotic withdrawal: evaluation and treatment. Lifshitz M, Gavrilov V, Galil A, Landau D. Isr Med Assoc J; 2001 Jan 12; 3(1):17-20. PubMed ID: 11344794 [Abstract] [Full Text] [Related]
18. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy. Hamilton R, McGlone L, MacKinnon JR, Russell HC, Bradnam MS, Mactier H. Br J Ophthalmol; 2010 Jun 12; 94(6):696-700. PubMed ID: 20410537 [Abstract] [Full Text] [Related]